Purine P1 receptor-dependent immunostimulatory effects of antiviral acyclic analogues of adenine and 2,6-diaminopurine

Citations of this article
Mendeley users who have this article in their library.
Get full text


Acyclic nucleoside phosphonates are widely recognised antivirals. The oral prodrugs of prototype compounds, e.g., 9-[2-(phosphonomethoxy)ethyl]adenine (PMEA; adefovir), and 9-(R)-[2-(phosphonomethoxy)propyl]adenine [(R)-PMPA; tenofovir] were approved by FDA for treatment of hepatitis B (Hepsera), and acquired immunodeficiency syndrome (AIDS) (Viread), respectively. A number of acyclic nucleoside phosphonates possess immunostimulatory activity. The present experiments demonstrate that activation of cytokine and chemokine secretion is mediated by adenosine receptors. Included in the study were 9-(R)-[2- (phosphonomethoxy)propyl]adenine [tenofovir], N6-cyclopentyl-(R)-9- [2-(phosphonomethoxy)propyl]-2,6-diaminopurine, N6-cyclopropyl-(R)-9- [2-(phosphonomethoxy)propyl]-2,6-diaminopurine, and N6-isobutyl-9-[2- (phosphonomethoxy)ethyl]-2,6-diaminopurine. All of them activate secretion of tumor necrosis factor-α (TNF-α), interleukin-10 (IL-10), "regulated on activation of normal T cell expressed and secreted" (RANTES/CCL5), and macrophage inflammatory protein-1α (MIP-1α/CCL3) in murine macrophages. With exception of MIP-1α, the effects were inhibited by antagonists of adenosine A1, A2B, and A 3 receptors (not by adenosine A2A receptor antagonist). The adenosine A1 receptor antagonist inhibited TNF-α, IL-10, and RANTES, adenosine A2B receptor antagonist inhibited TNF-α and RANTES, and adenosine A3 receptor antagonist inhibited IL-10 and RANTES. The suppression is due to decreased transcription of cytokine mRNA. It may be suggested that acyclic nucleoside phosphonates are nonspecific ligands for purine P1 receptors. © 2005 Elsevier B.V. All rights reserved.




Kmoníčková, E., Potměšil, P., Holý, A., & Zídek, Z. (2006). Purine P1 receptor-dependent immunostimulatory effects of antiviral acyclic analogues of adenine and 2,6-diaminopurine. European Journal of Pharmacology, 530(1–2), 179–187. https://doi.org/10.1016/j.ejphar.2005.11.037

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free